- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02779387
Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy
May 19, 2016 updated by: Yu xiaoming, Peking University People's Hospital
Efficacy of Laparoscopic Surgery Combined With GnRH-a in the Treatment of Endometriosis Associated Infertility: A Multicenter, Prospective, Randomized-control-trial
This study is a multicenter, randomized-control-trial.
This study select 1184 Infertile patients associated with endometriosis diagnosed by laparoscopy surgery.
Patients are going to be divided into two groups according to 1:1 ratio randomly assigned to receive GnRH-a.
Cumulative pregnancy rate, end of treatment to natural pregnancy time, accept the assisted reproductive treatment rate, miscarriage rate, live birth rate will be recorded.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
1184
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 35 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Infertile patients
- Endometriosis I-II phase:according to Revised American Society for Reproductive Medicine classification of endometriosis: 1996
- BMI:19-28 kg/㎡
- Ovarian reserve function is normal(M2-5:bilateral antral follicles≥6 FSH:5-12U/ml)
Exclusion Criteria:
- Male factor causes infertility
- hydrosalpinx or salpingemphraxis
- Uterine malformation
- Uterine cavity lesion
- Contra-indications for GnRH-a
- not willing to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: GnRH-a
patients treated with GnRH-a after surgery and Outpatient guidance . |
|
|
NO_INTERVENTION: non GnRH-a
patients treated with outpatient guidance only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cumulative pregnancy rate
Time Frame: 18 month after surgery
|
Cumulative pregnancy rate of 18 month after surgery
|
18 month after surgery
|
|
Time interval between surgery and natural pregnancy
Time Frame: 18 month after surgery
|
Time interval between surgery and natural pregnancy
|
18 month after surgery
|
|
miscarriage rate
Time Frame: 18 month after surgery
|
miscarriage rate of patients who get natural pregnancy
|
18 month after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (ANTICIPATED)
May 1, 2020
Study Completion (ANTICIPATED)
May 1, 2021
Study Registration Dates
First Submitted
May 18, 2016
First Submitted That Met QC Criteria
May 19, 2016
First Posted (ESTIMATE)
May 20, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
May 20, 2016
Last Update Submitted That Met QC Criteria
May 19, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PKU01001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Willing to share IPD
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility Associated With Endometriosis
-
Hospital Clinic of BarcelonaCompleted
-
Monath ElectronicRecruitingEndometriosis | Pelvic Pain Associated With Refractory Endometriosis | Pelvic Pain Associated With Endometriosis or AdenomyosisFrance
-
Uludag UniversityUnknownEndometriosis Related InfertilityTurkey
-
Mereo BioPharmaNovartisTerminatedPelvic Pain Associated With Refractory EndometriosisUnited States, Puerto Rico
-
University Hospital, Basel, SwitzerlandMerck Serono International SACompletedComplications Associated With Artificial Fertilization | Female Infertility Due to Nonimplantation of OvumSwitzerland
-
Ahmed Fathy Ali Mohamed GhanemCompletedFemale Infertility Associated With Anovulation
-
Benha UniversityCompletedInfertility, Female, Associated With AnovulationEgypt
-
Istanbul UniversityCompletedInfertility, Female | Endometriosis OvariesTurkey
-
Benha UniversityCompletedEndometriosis | Infertility UnexplainedEgypt
-
Royan InstituteRecruitingEndometrioma | Female Infertility | Stress OxidativeIran, Islamic Republic of
Clinical Trials on Goserelin Acetate
-
CMX ResearchPeptigroupe Inc.CompletedProstate CancerCanada, Georgia
-
Eurofarma Laboratorios S.A.Terminated
-
Luye Pharma Group Ltd.Completed
-
AstraZenecaWithdrawn
-
AstraZenecaCompletedAdvanced Breast CancerRussian Federation, Ukraine, Czech Republic
-
Luye Pharma Group Ltd.CompletedProstate CancerChina
-
Luye Pharma Group Ltd.Completed
-
424 General Military HospitalAristotle University Of Thessaloniki; 251 Hellenic Air Force & VA General HospitalCompletedEndometriosis | Bone Density | Muscle | Bone MetabolismGreece
-
Ferring PharmaceuticalsTerminatedProstate CancerUnited States, Netherlands, United Kingdom, Hungary, Belgium, Czech Republic, Finland, Germany, Mexico, Poland, Romania, Ukraine, Canada
-
AstraZenecaCompleted